Millennium Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500,000
Closed -$5.89M 5768
2025
Q4
$5.89M Buy
+500,000
New +$6.42M ﹤0.01% 2830
2023
Q3
Sell
-75,000
Closed -$2.77M 6158
2023
Q2
$2.77M Hold
75,000
﹤0.01% 3197
2023
Q1
$2.25M Buy
+75,000
New +$2.47M ﹤0.01% 3330
2021
Q1
Sell
-45,000
Closed -$1.12M 5962
2020
Q4
$1.12M Buy
+45,000
New +$1.07M ﹤0.01% 3669
2020
Q3
Sell
-70,000
Closed -$1.07M 4476
2020
Q2
$1.07M Sell
70,000
-30,000
-30% -$379K ﹤0.01% 2948
2020
Q1
$887K Hold
100,000
﹤0.01% 2541
2019
Q4
$1.81M Buy
100,000
+24,800
+33% +$412K ﹤0.01% 2677
2019
Q3
$1.12M Buy
75,200
+57,200
+318% +$930K ﹤0.01% 2784
2019
Q2
$432K Buy
+18,000
New +$530K ﹤0.01% 3332

Other funds holding CC

Millennium Management's CC Position: Q1 2026 in Review

Millennium Management reduced its Chemours (CC) stake by 84% in Q1 2026, selling an estimated $32.6M and leaving 365,504 shares worth $8.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

Millennium Management first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $196M in Q3 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Millennium Management held 365,504 shares of Chemours worth $8.05M as of Q1 2026.
  • Millennium Management sold 1,874,186 Chemours shares in Q1 2026, an estimated $32.6M.
  • Chemours made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2394 holding.
  • Millennium Management first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • Millennium Management's Chemours position peaked at $196M in Q3 2017.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.